Title | Type | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | %Female (2015) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cochrane Database of Systematic Reviews | journal | 2.585 Q1 | 327 | 1673 | 4385 | 128983 | 23115 | 4336 | 4.25 | 77.10 | 45.26 | |
2 | Journal of Antimicrobial Chemotherapy | journal | 2.259 Q1 | 221 | 389 | 1737 | 10290 | 7742 | 1474 | 4.14 | 26.45 | 44.70 | |
3 | Alimentary Pharmacology and Therapeutics | journal | 3.079 Q1 | 207 | 417 | 1308 | 11315 | 5278 | 705 | 4.08 | 27.13 | 31.29 | |
4 | Rheumatology | journal | 2.085 Q1 | 198 | 321 | 1237 | 8331 | 4665 | 939 | 3.59 | 25.95 | 43.82 | |
5 | Trials | journal | 1.235 Q1 | 98 | 594 | 1197 | 24419 | 2965 | 1176 | 2.23 | 41.11 | 44.69 | |
6 | British Journal of Clinical Pharmacology | journal | 1.511 Q1 | 167 | 271 | 791 | 11580 | 2965 | 654 | 3.92 | 42.73 | 41.88 | |
7 | Expert Opinion on Pharmacotherapy | journal | 0.907 Q2 | 93 | 251 | 734 | 17110 | 2183 | 705 | 3.15 | 68.17 | 32.16 | |
8 | International Journal of STD and AIDS | journal | 0.753 Q2 | 78 | 174 | 630 | 4767 | 752 | 592 | 1.33 | 27.40 | 49.74 | |
9 | Pharmacoepidemiology and Drug Safety | journal | 1.908 Q1 | 109 | 164 | 586 | 4990 | 1608 | 517 | 2.73 | 30.43 | 41.35 | |
10 | Acta Pharmacologica Sinica | journal | 1.136 Q1 | 117 | 152 | 548 | 7530 | 1739 | 538 | 3.12 | 49.54 | 40.90 | |
11 | International Journal of Neuropsychopharmacology | journal | 1.764 Q1 | 125 | 177 | 548 | 9768 | 2285 | 533 | 4.05 | 55.19 | 41.40 | |
12 | Orphanet Journal of Rare Diseases | journal | 1.522 Q1 | 136 | 168 | 547 | 6381 | 2283 | 543 | 3.72 | 37.98 | 52.14 | |
13 | Expert Review of Anticancer Therapy | journal | 0.795 Q2 | 85 | 127 | 473 | 8904 | 1016 | 449 | 2.07 | 70.11 | 33.40 | |
14 | CNS Neuroscience and Therapeutics | journal | 1.553 Q1 | 91 | 125 | 464 | 6311 | 1557 | 348 | 3.27 | 50.49 | 40.61 | |
15 | Drugs | journal | 1.683 Q1 | 188 | 168 | 457 | 11109 | 2473 | 447 | 5.75 | 66.13 | 41.98 | |
16 | Expert Review of Neurotherapeutics | journal | 1.037 Q2 | 98 | 110 | 448 | 8907 | 1298 | 413 | 2.60 | 80.97 | 31.90 | |
17 | Expert Opinion on Investigational Drugs | journal | 1.341 Q1 | 117 | 132 | 440 | 11218 | 1719 | 434 | 3.84 | 84.98 | 32.36 | |
18 | Journal of Psychopharmacology | journal | 1.775 Q1 | 135 | 128 | 439 | 8796 | 1837 | 412 | 3.95 | 68.72 | 37.81 | |
19 | Antiviral Therapy | journal | 1.388 Q1 | 93 | 107 | 425 | 3198 | 1177 | 409 | 2.76 | 29.89 | 43.96 | |
20 | Drug and Therapeutics Bulletin | journal | 0.138 Q3 | 17 | 138 | 425 | 984 | 43 | 123 | 0.13 | 7.13 | 0.00 | |
21 | Clinical Drug Investigation | journal | 0.664 Q2 | 67 | 97 | 346 | 2682 | 690 | 328 | 1.98 | 27.65 | 39.70 | |
22 | Expert Opinion on Drug Safety | journal | 1.058 Q1 | 90 | 164 | 341 | 12223 | 1142 | 332 | 3.37 | 74.53 | 37.57 | |
23 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.708 Q2 | 81 | 124 | 339 | 3722 | 717 | 334 | 2.22 | 30.02 | 45.07 | |
24 | Drug Safety | journal | 1.365 Q1 | 140 | 104 | 320 | 5108 | 1101 | 281 | 3.60 | 49.12 | 46.24 | |
25 | Journal of Biomedical Science | journal | 1.316 Q1 | 110 | 100 | 300 | 5106 | 1068 | 300 | 3.36 | 51.06 | 41.41 | |
26 | HIV Medicine | journal | 1.967 Q1 | 86 | 99 | 287 | 3211 | 989 | 264 | 3.14 | 32.43 | 43.36 | |
27 | Drugs and Aging | journal | 1.389 Q1 | 109 | 98 | 280 | 6080 | 1032 | 265 | 3.45 | 62.04 | 46.03 | |
28 | CNS Drugs | journal | 1.767 Q1 | 129 | 77 | 270 | 6587 | 1463 | 254 | 5.60 | 85.55 | 44.82 | |
29 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.818 Q2 | 61 | 103 | 253 | 4429 | 519 | 243 | 1.81 | 43.00 | 41.37 | |
30 | Expert Review of Clinical Pharmacology | journal | 0.817 Q2 | 60 | 58 | 249 | 4113 | 574 | 215 | 2.41 | 70.91 | 34.68 | |
31 | Fundamental and Clinical Pharmacology | journal | 0.637 Q2 | 85 | 64 | 232 | 2798 | 485 | 232 | 2.39 | 43.72 | 48.31 | |
32 | Human Psychopharmacology | journal | 0.974 Q2 | 86 | 52 | 232 | 2845 | 657 | 227 | 3.03 | 54.71 | 42.80 | |
33 | Clinical Practice | journal | 0.133 Q4 | 10 | 5 | 230 | 87 | 60 | 193 | 0.27 | 17.40 | 54.55 | |
34 | Expert Opinion on Orphan Drugs | journal | 0.213 Q3 | 27 | 124 | 230 | 10230 | 120 | 227 | 0.52 | 82.50 | 43.06 | |
35 | Journal of Oncology Pharmacy Practice | journal | 0.424 Q3 | 44 | 50 | 227 | 1205 | 260 | 214 | 1.01 | 24.10 | 46.41 | |
36 | Clinical Pharmacokinetics | journal | 1.664 Q1 | 184 | 108 | 217 | 5585 | 1271 | 210 | 5.60 | 51.71 | 35.35 | |
37 | Drugs and Therapy Perspectives | journal | 0.112 Q4 | 13 | 72 | 216 | 1854 | 12 | 216 | 0.06 | 25.75 | 55.77 | |
38 | Journal of Chemotherapy | journal | 0.512 Q2 | 56 | 70 | 195 | 1923 | 277 | 175 | 1.28 | 27.47 | 42.62 | |
39 | Cardiovascular Therapeutics | journal | 1.259 Q1 | 54 | 50 | 192 | 1995 | 578 | 181 | 2.50 | 39.90 | 29.02 | |
40 | European Journal of Contraception and Reproductive Health Care | journal | 0.653 Q2 | 53 | 52 | 179 | 1449 | 232 | 169 | 1.30 | 27.87 | 64.76 | |
41 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.110 Q1 | 57 | 60 | 177 | 2823 | 515 | 172 | 3.10 | 47.05 | 30.39 | |
42 | Psychiatry and Clinical Psychopharmacology | journal | 24 | 65 | 167 | 2023 | 64 | 145 | 0.35 | 31.12 | 38.26 | ||
43 | BMC pharmacology & toxicology | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | 35.20 | |
44 | Pharmaceutical Statistics | journal | 1.180 Q1 | 46 | 57 | 160 | 1388 | 177 | 149 | 1.20 | 24.35 | 32.10 | |
45 | Clinical Pharmacist | journal | 0.111 Q4 | 11 | 69 | 153 | 568 | 4 | 99 | 0.01 | 8.23 | 54.90 | |
46 | Biopharmaceutics and Drug Disposition | journal | 0.733 Q2 | 65 | 52 | 149 | 1987 | 408 | 144 | 2.66 | 38.21 | 28.36 | |
47 | BioDrugs | journal | 0.894 Q2 | 79 | 35 | 146 | 2111 | 483 | 141 | 3.39 | 60.31 | 42.31 | |
48 | Paediatric Drugs | journal | 0.855 Q2 | 70 | 50 | 142 | 3028 | 340 | 136 | 2.56 | 60.56 | 56.74 | |
49 | American Journal of Cardiovascular Drugs | journal | 0.920 Q2 | 60 | 44 | 128 | 2273 | 322 | 121 | 2.49 | 51.66 | 21.43 | |
50 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 54 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | 36.77 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®